Deep Intelligent Pharma
Singapore · Founded 2017
About Deep Intelligent Pharma
Deep Intelligent Pharma (DIP) is a Singapore-based AI company that helps pharmaceutical and biotech companies run clinical trials faster, cheaper, and with fewer mistakes. Its AI platform automates many slow and manual tasks, such as writing trial documents, designing studies, analyzing data, translating medical content for global regulators, and preparing regulatory submissions. By using thousands of small AI agents supervised by experts, DIP not only saves time but also helps improve the chance that a clinical trial will succeed. Its technology has already been proven in real cases, including an AI-written protocol approved by Japan’s regulator with no revisions. Today, DIP works with over 1,000 life science companies worldwide, including major names like Bayer, Johnson & Johnson, and Roche.
Company Facts
- Founded: 2017
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $131.6M
- Funding stage: Late Stage Venture
- Last round: Series D (Feb 2026)
- Website: https://www.dip-ai.com/
- Phone: 010-86225158
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/deep-intelligent-pharma-30636 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.